Substrate and Inhibitor Specificity of the Type II p21-Activated Kinase, PAK6
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Substrate and Inhibitor Specificity of the Type II p21-Activated Kinase, PAK6
Authors
Keywords
Phosphorylation, Crystal structure, Small molecules, Kinase inhibitors, Molecular structure, Peptide libraries, Androgens, Melanomas
Journal
PLoS One
Volume 8, Issue 10, Pages e77818
Publisher
Public Library of Science (PLoS)
Online
2013-10-29
DOI
10.1371/journal.pone.0077818
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Functional Deficits in Pak5, Pak6 and Pak5/Pak6 Knockout Mice
- (2013) Melody A. Furnari et al. PLoS One
- Collaboration gets the most out of software
- (2013) Andrew Morin et al. eLife
- Pak6 protein kinase is a novel effector of an atypical Rho family GTPase Chp/RhoV
- (2012) M. V. Shepelev et al. BIOCHEMISTRY-MOSCOW
- A Novel Approach to the Discovery of Small-Molecule Ligands of CDK2
- (2012) Mathew P. Martin et al. CHEMBIOCHEM
- Group I and II mammalian PAKs have different modes of activation by Cdc42
- (2012) Yohendran Baskaran et al. EMBO REPORTS
- p21-activated Kinase 6 (PAK6) Inhibits Prostate Cancer Growth via Phosphorylation of Androgen Receptor and Tumorigenic E3 Ligase Murine Double Minute-2 (Mdm2)
- (2012) Tong Liu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma
- (2012) Michael Krauthammer et al. NATURE GENETICS
- Identification of neuronal substrates implicates Pak5 in synaptic vesicle trafficking
- (2012) T. I. Strochlic et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Type II p21-activated kinases (PAKs) are regulated by an autoinhibitory pseudosubstrate
- (2012) B. H. Ha et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Molecular conformations, interactions, and properties associated with drug efficiency and clinical performance among VEGFR TK inhibitors
- (2012) M. McTigue et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- REFMAC5 for the refinement of macromolecular crystal structures
- (2011) Garib N. Murshudov et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Overview of theCCP4 suite and current developments
- (2011) Martyn D. Winn et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Presenting your structures: theCCP4mgmolecular-graphics software
- (2011) S. McNicholas et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- LigPlot+: Multiple Ligand–Protein Interaction Diagrams for Drug Discovery
- (2011) Roman A. Laskowski et al. Journal of Chemical Information and Modeling
- Exome sequencing identifies GRIN2A as frequently mutated in melanoma
- (2011) Xiaomu Wei et al. NATURE GENETICS
- Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors
- (2011) Eric Raymond et al. NEW ENGLAND JOURNAL OF MEDICINE
- Features and development ofCoot
- (2010) P. Emsley et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- PHENIX: a comprehensive Python-based system for macromolecular structure solution
- (2010) Paul D. Adams et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Crystal Structures of IL-2-inducible T cell Kinase Complexed with Inhibitors: Insights into Rational Drug Design and Activity Regulation
- (2010) Alan K. Kutach et al. Chemical Biology & Drug Design
- Small-molecule p21-activated kinase inhibitor PF-3758309 is a potent inhibitor of oncogenic signaling and tumor growth
- (2010) B. W. Murray et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- MolProbity: all-atom structure validation for macromolecular crystallography
- (2009) Vincent B. Chen et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Targeting group II PAKs in cancer and metastasis
- (2009) Jeyanthy Eswaran et al. CANCER AND METASTASIS REVIEWS
- PAK signaling in oncogenesis
- (2009) P R Molli et al. ONCOGENE
- KIT kinase mutants show unique mechanisms of drug resistance to imatinib and sunitinib in gastrointestinal stromal tumor patients
- (2009) K. S. Gajiwala et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A tale of two Paks
- (2008) Luis E. Arias-Romero et al. BIOLOGY OF THE CELL
- Targeted disruption of the Pak5 and Pak6 genes in mice leads to deficits in learning and locomotion
- (2008) Tanya Nekrasova et al. DEVELOPMENTAL BIOLOGY
- Automated macromolecular model building for X-ray crystallography using ARP/wARP version 7
- (2008) Gerrit Langer et al. Nature Protocols
- A conserved protonation-dependent switch controls drug binding in the Abl kinase
- (2008) Y. Shan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Increased PAK6 expression in prostate cancer and identification of PAK6 associated proteins
- (2008) Ramneet Kaur et al. PROSTATE
- UnPAKing the class differences among p21-activated kinases
- (2008) Jeyanthy Eswaran et al. TRENDS IN BIOCHEMICAL SCIENCES
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now